Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life (QUALVIDON)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03296111|
Recruitment Status : Terminated (Difficulties for patients inclusion)
First Posted : September 28, 2017
Last Update Posted : October 30, 2019
Some patients with dry eye may have severe disabling neuropathic pain. They describe spontaneous pain, dysesthesia, hyperalgesia or even allodynia. It is classical to note an important discordance between the high intensity of the symptoms and the poverty of the clinical signs. These pains are often unrecognized and therefore often not sufficiently treated. A significant impact on patient's quality of life may occur. The concept of ocular neuropathic pain being relatively recent, few studies have focused on the subject at present. Our study aims to shed light on these pains in patients consulting for dry eyes at the Ophthalmological Foundation A. de Rothschild.
The objective of our study is to describe precisely the characteristics of neuropathic eye pain and the visual, general and psychological repercussions in these patients.
|Condition or disease||Intervention/treatment|
|Dry Eye Syndromes Neuralgia Pain Quality of Life||Other: Questionnaires on pain and quality of life|
|Study Type :||Observational|
|Actual Enrollment :||19 participants|
|Official Title:||Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life|
|Actual Study Start Date :||May 4, 2017|
|Actual Primary Completion Date :||June 19, 2017|
|Actual Study Completion Date :||October 28, 2019|
- Other: Questionnaires on pain and quality of life
Patients will be asked to complete several questionnaires about their pain and the impact on their quality of life.
They will complete the questionnaires in the ophthalmology consultation room or at home and return it by mail (or present it at the next consultation).
Patients will be asked to complete several questionnaires :
- Questionnaire about the characteristics of ocular neuropathic pain (7 items)
- DEQ-5 (Dry Eye Questionnaire)
- ODI (Ocular Surface Disease Index)
- BPI (Brief Pain Inventory)
- HADS (Hospital Anxiety and Depression Scale)
- Scores obtained with each questionnaires. [ Time Frame: baseline ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03296111
|Fondation Ophtamologique A. de Rothschild|
|Paris, France, 75019|